Importation Of Us-labelled Dexrazoxane For Injection Distributed By Mylan Pharmaceuticals Ulc Due To Shortage Of Canadian-labelled Dexrazoxane
Dexrazoxane for Injection Recall Summary Mylan Pharmaceuticals ULC is recalling US-labelled Dexrazoxane for Injection that was distributed across Canada as a substitute for Canadian-labelled versions during a shortage. The recall is being issued due to product safety concerns related to the use of US labelling on medication intended for the Canadian market.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2020-12-01
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/298fd00c-57b5-4381-8179-105400084649